Kamran Lab


There is an urgent need to individualize radiation therapy for patients to improve outcomes and quality of life. The Kamran lab focuses on the application of computational genomic approaches to characterize tumor evolution to treatment, understand mechanisms of radiotoxicity and radioresistance, and explore the radiation-antitumor immunity interaction. In addition, we are interested in dissecting translational science in diverse populations, something that is imperative to the field of oncology. It is essential that these populations are not left behind in the field of translational genomics.


December 13, 2023: What are the trends in bladder cancer-specific mortality in the US over two decades? Check out our work published in Bladder Cancer.

December 12, 2023: Read about Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer.

October 3, 2023: Resident Javier Mora MD presents our research on radiation-associated lymphopenia in advanced prostate cancer patients at ASTRO 2023. 

September 15, 2023: How did the change in NCCN guidelines for testicular seminoma in 2012 impact outcomes? Check out our findings here. 

July 3, 2023: Our work on Hispanic cancer mortality trends is featured in US News!

June 30, 2023: Check out Mass General Brigham‘s feature of our article. 

June 29, 2023: What are the trends in cancer mortality rates among Hispanic individuals over two decades? Check out our findings published in JAMA Oncology.

March 28, 2023: Dr. Kamran receives the Harvard Medical School Harold Amos Faculty Diversity Award. 

February 10, 2023: Check out our analysis of “manels” at ASCO Annual Meetings here.

January 31, 2023: Our work is featured on Mass General’s website!

January 19, 2023: A real-world precision oncology data registry does not have sufficient representation of minorities. Read our analysis of GENIE here.

December 13, 2022: Read about The Legacy of RTOG/NRG Protocols in Shaping Current Bladder Preservation Therapy in North America.

November 8, 2022: Read about Demographic Trends Among American Society for Radiation Oncology Clinical Practice Guideline Task Force Participants From 2010 to 2022

October 26, 2022: Dr. Kamran gives a talk about tumor-immune dynamics and precision oncology in prostate cancer at the Prostate Cancer Foundation Scientific Retreat.

October 24, 2022: Dr. Kamran presents at ASTRO 2022 on Genomic determinants of response to trimodality therapy for muscle-invasive bladder cancer.

October 17, 2022: Dr. Kamran presents at Radiation Research Society 2022 on Genomic characterization and biomarkers of chemoradiation resistance.

September 28, 2022: Dr. Kamran is appointed Director of Diversity, Equity, and Inclusion in the Radiation Oncology Department. Read her interview here

August 3, 2022: Welcome to Cameron Hayes and Arian Mansur!

July 29, 2022: Read about socioeconomic diversity in U.S. medical schools and the physician workforce here published in Frontiers. 

July 6, 2022: Welcome to Elina Palapattu!

July 5, 2022: Welcome to David Qi!

June 6, 2022: Welcome to Bella Pompa!

June 6, 2022: Dr. Kamran presents at ASCO 2022 on gender equity of scientific presentations. Read more about manels here.

May 16, 2022: Read about the Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening with Prostate Cancer-Specific Mortality in JAMA Network.

April 6, 2022: Read an Intersectional Analysis of U.S. Medical Faculty Diversity over Four Decades in The New England Journal of Medicine. 

February 19, 2022: Anushka Ghosh presents her poster on disparities in testicular cancer mortality at GU ASCO 2022.

February 17, 2022: Laura Burgess presents her poster on the Impact of U.S. Preventative Services Task Force Grade D Recommendation against PSA Screening on Prostate Cancer Mortality at GU ASCO 2022.

December 14, 2021: Dr. Kamran receives the Prostate Cancer Foundation (PCF) Young Investigator Award for TCR sequencing of oligometastatic prostate cancer.

December 9, 2021: To treat a diverse population, we need a more diverse workforce. Read more about how to recruit and retain individuals who are underrepresented in medicine here.

December 1, 2021All abstracts have been accepted to GU ASCO! 

November 8, 2021: Representation in clinical studies is vital! Check out our new paper about Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies in the JAMA Network.

November 3, 2021: Read about Solving the Stereotactic Body Radiotherapy and Checkpoint Inhibitor Puzzle in Metastatic Renal Cell Carcinoma in European Oncology.

October 27, 2021: Read about the importance of treating race as a social construct while also ensuring a diverse study population here. An absolute must read to make genomics research more equitable!

October 12, 2021: GU ASCO 2022 abstracts submitted!

October 5, 2021: Characterization of an Iodinated Rectal Spacer for Prostate Photon and Proton Radiotherapy – Paper published in Practical Radiation Oncology

July 28, 2021: Welcome to Siri Ragala!

July 13, 2021: Welcome to Melissa Huynh!

June 17, 2021: Welcome to Nabeel Rasheed!

April 1, 2021: ASCO 2021 abstracts accepted!

March 1, 2021: ASTRO abstracts submitted!

February 22, 2021: Welcome to Anushka Ghosh! 

February 1, 2021: Welcome to Laura Burgess! 

January 1, 2021: Welcome to Chris Aldrighetti! 

Get In Touch!

Mass General Hospital

100 Blossom Street

Boston, MA 02114

Comments are closed.